Takeda Pharmaceutical Company Limited Increase Decrease Through Change In Discount Rate Contingent Liabilities Recognised In Business Combination
Takeda Pharmaceutical Company Limited (TAK) reported Increase Decrease Through Change In Discount Rate Contingent Liabilities Recognised In Business Combination of JPY 374.00 million for the 12-month period ending 2021-03-31, per its 20-F filed 2021-06-29.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughChangeInDiscountRateContingentLiabilitiesRecognisedInBusinessCombination · last filed 2021-06-29
| Period end | Increase Decrease Through Change In Discount Rate Contingent Liabilities Recognised In Business Combination 12 month | Increase Decrease Through Change In Discount Rate Contingent Liabilities Recognised In Business Combination 12 month as first filed |
|---|---|---|
| 2021-03-31 | 374.00M JPY 20-F · filed 2021-06-29 | |
| 2020-03-31 | -1.43B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | -146.00M JPY 20-F · filed 2020-06-24 | 175.00M JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | -1.24B JPY 20-F · filed 2019-06-27 |